REQUEST A DEMO
Total
USD $0.00
Search more companies

Transmed Sp. z o.o. (Poland)

Main Activities: All Other Miscellaneous Ambulatory Health Care Services
Full name: Transmed Sp. z o.o. Profile Updated: April 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Transmed Sp. z o.o. is an enterprise based in Poland. Its main office is in Radlin. The company operates in the All Other Miscellaneous Ambulatory Health Care Services industry. The enterprise was incorporated on July 13, 2007. It currently has a total number of 1 (2015) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 23.55% in 2023. During that time, Transmed Sp. z o.o.’s total assets grew by 18.94%. In, 2023, the company’s net profit margin decreased by 0.78%.

Headquarters
Ul. Reymonta 9
Radlin; Slaskie; Postal Code: 44-310

Contact Details: Purchase the Transmed Sp. z o.o. report to view the information.

Website: http://www.transmed.pl

Basic Information
Total Employees:
Purchase the Transmed Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Transmed Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Transmed Sp. z o.o. report to view the information.
Incorporation Date:
July 13, 2007
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
30%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Transmed Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
23.55%
Total operating revenue
15.15%
Operating profit (EBIT)
-1.99%
EBITDA
20.92%
Net Profit (Loss) for the Period
3.91%
Total assets
18.94%
Total equity
19.93%
Operating Profit Margin (ROS)
-1.15%
Net Profit Margin
-0.78%
Return on Equity (ROE)
-2.56%
Quick Ratio
0.18%
Cash Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?